Changeflow GovPing Healthcare & Life Sciences CHMP Meeting 14-17 September 2026 Amsterdam
Routine Notice Added Final

CHMP Meeting 14-17 September 2026 Amsterdam

Favicon for www.ema.europa.eu EMA CHMP Agendas & Minutes
Detected
Email

Summary

The European Medicines Agency has scheduled a Committee for Medicinal Products for Human Use (CHMP) meeting for 14-17 September 2026 in Amsterdam, the Netherlands. CHMP is responsible for preparing the Agency's opinions on all questions concerning human medicines. The meeting will take place at the European Medicines Agency headquarters and appears on the Agency's public events calendar with links to external calendar applications.

“The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.”

EMA , verbatim from source
Published by EMA on ema.europa.eu . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

The European Medicines Agency's Committee for Medicinal Products for Human Use meets monthly to issue scientific opinions on applications for EU marketing authorization. This feed tracks the agendas and highlights from each CHMP meeting: new medicines under review, indication extensions, line extensions, refusals, and safety-related referrals. Around 7 major publications a year with interim updates, but each carries high weight because CHMP opinions drive European Commission authorization decisions within weeks. Watch this if you file EMA applications, advise on European pharma regulatory strategy, track competitor pipeline decisions at the scientific-opinion stage, or follow safety referrals that often previewed global label changes.

What changed

The European Medicines Agency has published notice of an upcoming CHMP (Committee for Medicinal Products for Human Use) meeting scheduled for 14-17 September 2026 in Amsterdam. The CHMP is the EMA committee responsible for preparing opinions on human medicines questions. This is a routine meeting announcement providing date, location, and calendar integration details — no regulatory opinions, guidance, or compliance obligations are contained in this notice. Stakeholders monitoring EMA drug review processes may wish to track outcomes from this meeting for any medicines under evaluation.

Meeting

Date
2026-09-14
Location
Amsterdam, the Netherlands

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2026

Event Human Medicines Add to calendar
- Google Calendar
- Apple Calendar
- Office365 Calendar
- Outlook Calendar
- Yahoo Calendar

Date

Monday, 14 September

-

Thursday, 17 September 2026

,

All day

Location

European Medicines Agency, Amsterdam, the Netherlands The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

Related information

Share this page

Mentioned entities

Get daily alerts for EMA CHMP Agendas & Minutes

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EMA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EMA
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug review Committee meeting Regulatory opinion
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Healthcare Public Health

Get alerts for this source

We'll email you when EMA CHMP Agendas & Minutes publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!